AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 9 added, 1 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- 10+ awardsAwards on record
Key stats
Fundamentals Sep 27- Open
- $28.26
- 52-wk high
- $41.82
- High
- $28.34
- 52-wk low
- $19.68
- Low
- $27.54
- Prev close
- $28.56
- Mkt cap
- $20.24B
- Volume
- 8.84M
- Fwd P/E
- 14.1x
- Beta
- 0.42
- Div yield
- 4.90%
- P/S
- 0.5x
- P/B
- 1.3x
- Profit margin
- -3.1%
- Op margin
- +11.6%
- ROE
- -5.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about DOW filings
Are insiders buying or selling Dow Inc (DOW) stock?
Neither. Dow Inc (DOW) insiders filed no open-market purchases or sales in the 90 days to Sep 27, 2026, according to SEC Form 4 filings.
Which members of Congress have traded DOW recently?
None. No member of Congress disclosed a DOW trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this DOW smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (3)
- TS
Two Sigma
$301.4M
added
- QR
Qube Research
$188.2M
bought
- DS
D.E. Shaw
$69.6M
added
How top traders are positioned
No tracked top-trader positions in DOW right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 15.2% above what analysts expected.
Earnings per share
$1.25 expected
Reports Oct 22, 2026, in 25 days
Estimates as of Sep 27, 2026
EPS expected
$0.57 to $0.81
Revenue expected
13 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $9.97B | $9.46B | $9.79B | $12.09B |
| Cost of what it sold | $9.28B | $8.91B | $9.15B | $9.93B |
| Gross profit | $689.0M | $548.0M | $640.0M | $2.17B |
| What it spent | ||||
| Research and development | $191.0M | $173.0M | $181.0M | $207.0M |
| Sales and admin | $340.0M | $339.0M | $417.0M | $535.0M |
| Other operating costs | — | $1.08B | $73.0M | $543.0M |
| Total operating expenses | $530.0M | $1.59B | $671.0M | $1.28B |
| What was left | ||||
| Operating profit | $159.0M | -$1.04B | -$31.0M | $882.0M |
| Interest on debt | $221.0M | $219.0M | $219.0M | $210.0M |
| Profit before tax | $70.0M | -$1.55B | -$390.0M | $871.0M |
| Tax | -$54.0M | -$71.0M | $55.0M | $69.0M |
| Net profit | $62.0M | -$1.54B | -$445.0M | $721.0M |
| EBITDA | $979.0M | -$621.0M | $195.0M | $1.75B |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace